Persistence and adherence with dupilumab therapy in patients with atopic dermatitis: a single-centre experience

被引:0
|
作者
Silverberg, J. I. [1 ]
Hong, M. [2 ]
机构
[1] George Washington Univ, Sch Med & Hlth Sci, Dept Dermatol, Washington, DC 20052 USA
[2] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
371
引用
收藏
页码:E78 / E78
页数:1
相关论文
共 50 条
  • [1] Single-centre experience with tralokinumab in dupilumab-experienced and naive patients with atopic dermatitis
    Fossati, Claire
    Guenova, Emmanuella
    Conrad, Curdin
    Gilliet, Michel
    Seremet, Teofila
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [2] Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience
    Simonetti, O.
    Radi, G.
    Diotallevi, F.
    Molinelli, E.
    Rizzetto, G.
    Offidani, A.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (05) : 939 - 940
  • [3] Long-Term Efficacy and Safety of Dupilumab in Patients with Atopic Dermatitis: A Single-Centre Retrospective Study
    Ortoncelli, Michela
    Macagno, Nicole
    Mastorino, Luca
    Gelato, Federica
    Richiardi, Irene
    Cavaliere, Giovanni
    Quaglino, Pietro
    Ribero, Simone
    [J]. COSMETICS, 2023, 10 (06)
  • [4] A single-centre real-life experience on effectiveness and safety of dupilumab in adolescents with severe atopic dermatitis in treatment with cyclosporine A
    Colonna, C.
    Zussino, M.
    Ponziani, A.
    Gelmetti, C.
    Monzani, N. A.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (08) : E533 - E535
  • [5] Management of atopic dermatitis in patients non-responsive to dupilumab: A single-centre retrospective-cohort study
    Greenzaid, Jonathan D.
    Hrin, Matthew L.
    Feldman, Steven R.
    Strowd, Lindsay C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [6] Real-world effectiveness and safety of dupilumab for the treatment of atopic dermatitis in Japanese patients: a single-centre retrospective study
    Uchida, H.
    Kamata, M.
    Mizukawa, I.
    Watanabe, A.
    Agematsu, A.
    Nagata, M.
    Fukaya, S.
    Hayashi, K.
    Fukuyasu, A.
    Tanaka, T.
    Ishikawa, T.
    Ohnishi, T.
    Tada, Y.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (05) : 1083 - 1085
  • [7] Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre
    Olesen, C. M.
    Holm, J. G.
    Norreslet, L. B.
    Serup, J. V.
    Thomsen, S. F.
    Agner, T.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (08) : 1562 - 1568
  • [8] Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry
    Li, Angelo
    Musters, Annelie H.
    Hyseni, Arienna
    Gerbens, Louise A. A.
    Spuls, Phyllis, I
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024,
  • [9] Real-world efficacy and safety of dupilumab in Chinese patients with atopic dermatitis: a single-centre, prospective, open-label study
    Gu, C.
    Wu, Y.
    Luo, Y.
    Wang, S.
    Yin, H.
    Gao, Y.
    Wang, C.
    Yao, X.
    Li, W.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) : 1064 - 1073
  • [10] Dupilumab for severe atopic dermatitis - real life experience in a portuguese tertiary centre
    Bras, R.
    Lopes, A.
    Neto, M.
    Spinola-Santos, A.
    Mendes, A.
    Costa, C.
    Pedro, E.
    Pereira-Barbosa, M.
    [J]. ALLERGY, 2020, 75 : 450 - 450